Isabelle André, Director of Research at Institut Imagine, joins the French Ministry of Higher Education, Research and Innovation as Scientific Director for the Health-Biology sector Read more about Isabelle André, Director of Research at Institut Imagine, joins the French Ministry of Higher Education, Research and Innovation as Scientific Director for the Health-Biology sector
Identification of a new mutation affecting the IRF4 gene associated with a primary immunodeficiency Read more about Identification of a new mutation affecting the IRF4 gene associated with a primary immunodeficiency
The cytoplasmic protein RIPK3 influences the severity of viral encephalitis due to herpes by limiting the viral load Read more about The cytoplasmic protein RIPK3 influences the severity of viral encephalitis due to herpes by limiting the viral load
Discovery of DOCK11 mutations responsible for a new X-linked autoimmune disease Read more about Discovery of DOCK11 mutations responsible for a new X-linked autoimmune disease
Covid-19: inborn errors responsible for multisystemic inflammatory syndrome in children Read more about Covid-19: inborn errors responsible for multisystemic inflammatory syndrome in children
A look back at the Dravet Syndrome Alliance Days Read more about A look back at the Dravet Syndrome Alliance Days
GénéTalks: conferences for the general public on genetics at the Institut Imagine Read more about GénéTalks: conferences for the general public on genetics at the Institut Imagine
A new gene therapy strategy for sickle cell disease and beta thalassemia Read more about A new gene therapy strategy for sickle cell disease and beta thalassemia
"The systematic screening of sickle cell disease extended to the entire French population is a real victory". Read more about "The systematic screening of sickle cell disease extended to the entire French population is a real victory".
Institut Imagine: a partnership strategy to accelerate research and innovation in genetic diseases Read more about Institut Imagine: a partnership strategy to accelerate research and innovation in genetic diseases
